Completed Transactions

Completed Transactions > Healthcare & Life Sciences > California Peptide Research acquired by a Private Investor

California Peptide Research acquired by a Private Investor

CaliforniaPeptide Header


Oct 2008



Based in Napa, California, California Peptide Research, Inc. (CPRI) produces custom peptides (biochemical "building blocks") and sells them to various research entities around the world. These peptides are used in medical research, pharmaceutical development and even cosmetics.

"CPRI was attractive to many buyers, due to its unique products and high profitability," said Bob Gurrola, who managed the transaction for M&A advisors Generational Equity. "Ultimately, CPRI's owners elected to sell to the buyer with a combination of price and terms, as well as a high personal comfort level, as the owners planned to continue working for the new owner." "There were many challenges in getting this deal done," explained Ryan Binkley, President of Generational Equity. "However, we went the extra mile to carefully explain the details to our client, who in the end was pleased with their deal."

About Generational Equity Generational Equity is one of the nation's leading middle-market mergers and acquisitions companies, providing private business owners with the information and expertise they require to exit their business successfully. A unique, four-phase approach that includes education, financial analysis and reporting, sales documentation and deal-making ability combine to offer business owners an unparalleled level of commitment and experience, all focused on helping to release the generational equity and wealth in every business. Generational Equity has more than 300 professional advisors and affiliates nationwide and is headquartered in Dallas, with affiliate offices in New York, Chicago and Irvine, Calif.

For more information, contact Generational Equity at (877) 213-1792 or [email protected], or visit